Xceleron, a leader in the application of ultrasensitive Accelerator Mass Spectrometry (AMS) to low-level quantitation of carbon isotopes, and Intertek, a global leader in providing quality and safety services to a wide range of industries, have entered into an agreement to help companies address their challenges in creating sustainable businesses. This agreement offers Intertek\u2019s customers a solution for measuring renewable, bio-based content in carbon-based materials, such as fuels, packaging and other matrices. This will enable them to more easily meet and report on corporate sustainability and social responsibility goals.<\/b> <\/p>\n
A \u2018bio-based product\u2019 is a commercial or industrial product (other than food or feed) that is composed, in whole or in part, of biological products or renewable agricultural (plant, animal and marine) or forestry materials. The AMS technology at Xceleron accurately measures renewable carbon content and, as part of Intertek\u2019s sustainability and social responsibility solutions, it will provide clients with a single source to assure their sustainability goals are met.<\/p>\n
“At Xceleron, we believe that technology can improve the lives of people by bringing them better products faster and cheaper. We recently became ISO17025 accredited and certified to ASTM D6866. Now our technology is made available to Intertek\u2019s international client base\u201d said Dr. Michael Butler, CEO of Xceleron.<\/p>\n
Dr. Ruud Overbeek, Vice President, Global Health, Environmental and Regulatory Services for Intertek said “Xceleron\u2019s technology is an excellent addition to the suite of services Intertek supplies to manufacturers of bio-based, renewable products. Adding this special technology to our complementary services portfolio will address our customer\u2019s demand for ensuring their products are truly eco-friendly and sustainable\u201d.<\/p>\n
About Xceleron<\/i><\/b>
Xceleron is an A2LA ISO\/IEC 17025:2005 (Certificate # 3411.01) Accredited ASTM D6866 Testing Laboratory. Xceleron provides biobased Accelerator Mass Spectrometry (AMS) services to determine the renewable carbon content in a wide range of biobased products for the consumer, household, plastics and biological fuels industries. Xceleron also provides bioanalytical AMS services for the pharmaceutical and biotechnology industries. The company pioneered human microdose and microtracer techniques using ultra-sensitive AMS to investigate the metabolism and pharmacokinetics of developmental drugs in human clinical trials, and has been a leading AMS service provider for more than 10 years.<\/p>\n